Study of AP23573/MK-8669 (Ridaforolimus), A Mammalian Target of Rapamycin (mTOR) Inhibitor, in Participants With Advanced Sarcoma (MK-8669-018 AM1)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
A 1-Year Study of an Investigational Drug in Obese Patients (0557-012)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE3
A 2-Year Study of an Investigational Drug in Obese Patients (0557-011)
- Status
- COMPLETED
- Phase
- PHASE3
A 6-Month Consumer Behavior Study of a Self-Management System (0803-084)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Gardasil (V501) in Preadolescents and Adolescents (V501-018)
- Status
- COMPLETED
- Phase
- PHASE3
Cervical Intraepithelial Neoplasm (CIN) in Women (Gardasil) (V501-015)
- Status
- COMPLETED
- Phase
- PHASE3
Cervical Intraepithelial Neoplasm (CIN)-Warts Efficacy Trial in Women (Gardasil)(V501-013)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE3
Study of an Investigational Vaccine in Pre-Adolescents and Adolescents (Gardasil)(V501-016)
- Status
- COMPLETED
- Phase
- PHASE3
Immunogenicity Bridge Between an Investigational Monovalent Vaccine and the Equivalent Component of Gardasil (V501) a Quadrivalent Vaccine (V501-012)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE3
Study of an Investigational Vaccine in Healthy Infants in Taiwan (V441-001)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE3
Consistency Lots Vaccine Study (V260-009)
- Status
- COMPLETED
- Phase
- PHASE3
Dose Confirmation Efficacy Study (V260-007)
- Status
- COMPLETED
- Phase
- PHASE3
Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016)
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of the Safety and Tolerability of a Higher Potency Dose of an Investigational Vaccine Among Adults 50 Years of Age and Older (V211-009)
- Status
- COMPLETED
- Phase
- PHASE3
Safety, Tolerability, and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age (V205C-009)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Two Approved Drugs in the Treatment of Post-Bunionectomy Surgery Pain (0966-234)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Two Approved Drugs in Patients With Osteoarthritis (0966-220)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Two Approved Drugs in Patients With Osteoarthritis (0966-219)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-190)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE3